文献速递急性肾损伤

术中更高血压未降低非心脏手术急性肾损伤:POISE-3试验结果解读

Higher intraoperative blood pressure does not reduce acute kidney injury in noncardiac surgery: what do the results of the POISE-3 trial tell us?
PubMed 文献 · Kidney Int · 2024-10-25

该文是对POISE-3随机对照试验预设分析的评论,探讨非心脏大手术中术中更高平均动脉压目标是否降低术后急性肾损伤(AKI)。结果显示,尽管干预组更多停用降压药且术中平均动脉压更高,但术后AKI发生率无差异。评论讨论了试验的优缺点及对临床实践的启示。

要点

  • 术中低血压与AKI相关,但提高术中平均动脉压目标未降低非心脏大手术后AKI发生率。
  • 干预组虽更多停用降压药且术中平均动脉压更高,AKI发生率仍无差异。
  • 该评论提示非心脏大手术中单纯提高术中血压目标可能不足以预防AKI。

核心结论

  • 在非心脏大手术中,以更高术中平均动脉压为目标的干预未降低术后急性肾损伤发生率。

研究设计与样本

  • 对POISE-3随机对照试验的预设分析进行评论,聚焦非心脏大手术中术中平均动脉压目标与术后AKI的关系。

主要发现

  • 干预组停用抗高血压药物的情况增加,且术中平均动脉压更高,但术后AKI发生率无差异。

临床怎么用

  • 非心脏大手术中,不应仅以提高术中平均动脉压为目标来预防术后AKI。

局限性

  • 评论指出需结合试验的优缺点解读结果,具体局限性未在摘要中详述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hypotension is a common cause of acute kidney injury (AKI), with strong associations between the duration and magnitude of hypotension seen across a range of situations including major surgery. However, it is less clear whether targeting higher intraoperative MAP results in lower rates of AKI. In a prespecified analysis of the Perioperative Ischemic Evaluation-3 (POISE-3) randomized controlled trial, this question is addressed for noncardiac major surgery. Despite an increase in cessation of antihypertensive medications and higher intraoperative mean arterial blood pressure in the intervention arm, no differences were seen in the rates of postoperative AKI. This commentary discusses the strengths and weaknesses of the trial, as well as providing some interpretation of results and their relevance to clinical practice.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Selby NM, Forni LG. Higher intraoperative blood pressure does not reduce acute kidney injury in noncardiac surgery: what do the results of the POISE-3 trial tell us? Kidney Int. 2024. PMID: 39490984. doi:10.1016/j.kint.2024.10.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。